ArticleMethods in molecular biology (Clifton, N.J.)2026
Production and Purification of Lentiviral Vectors.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lentiviral vectors are efficient genetic tools for neuroscience research. Among several kinds of lentiviral vectors, human immunodeficiency virus type 1 (HIV-1)-based lentiviral vectors have shown promise. Envelope glycoproteins studding the surface of viral particles play a crucial role in viral infection of host cells. Conventional lentiviral vectors are pseudotyped with vesicular stomatitis virus glycoprotein (VSV-G), and efficiently transfer the gene to different neurons. Lentiviral tropism can be manipulated by genetically engineering glycoproteins. Analyses of specific neural pathways are essential to understand brain functions controlled by complex neural circuits. Viral vectors ferrying transgenes via retrograde axonal transport provide a powerful tool for the analysis of neural pathways. We developed efficient lentiviral vectors for retrograde gene transfer in diverse neural pathways in animal models: highly efficient retrograde gene transfer (HiRet) and neuron-specific retrograde gene transfer (NeuRet) vectors. Both vectors are pseudotyped with fusion glycoproteins composed of rabies virus glycoprotein segments and VSV-G segments. HiRet/NeuRet vectors have been extensively used in neural pathway analysis. In this chapter, we describe the experimental procedures we developed for producing and purifying HIV-1-based VSV-G and HiRet/NeuRet vectors; we also present helpful points for conducting experiments smoothly and effectively.
Indexed as
Identifiers
41273637What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.